SMART Wealth LLC Makes New Investment in Intuitive Surgical, Inc. (NASDAQ:ISRG)

SMART Wealth LLC bought a new position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) during the 3rd quarter, according to its most recent 13F filing with the SEC. The fund bought 590 shares of the medical equipment provider’s stock, valued at approximately $290,000.

A number of other institutional investors and hedge funds have also made changes to their positions in ISRG. Hazlett Burt & Watson Inc. grew its position in Intuitive Surgical by 5.8% during the third quarter. Hazlett Burt & Watson Inc. now owns 362 shares of the medical equipment provider’s stock worth $177,000 after buying an additional 20 shares during the period. Mitchell Mcleod Pugh & Williams Inc. grew its holdings in shares of Intuitive Surgical by 4.1% in the 3rd quarter. Mitchell Mcleod Pugh & Williams Inc. now owns 503 shares of the medical equipment provider’s stock worth $247,000 after acquiring an additional 20 shares during the period. Ullmann Wealth Partners Group LLC increased its stake in Intuitive Surgical by 1.6% in the 3rd quarter. Ullmann Wealth Partners Group LLC now owns 1,329 shares of the medical equipment provider’s stock valued at $653,000 after purchasing an additional 21 shares in the last quarter. Meeder Advisory Services Inc. raised its holdings in Intuitive Surgical by 0.3% during the third quarter. Meeder Advisory Services Inc. now owns 7,386 shares of the medical equipment provider’s stock worth $3,629,000 after purchasing an additional 22 shares during the last quarter. Finally, One Wealth Management Investment & Advisory Services LLC boosted its position in Intuitive Surgical by 3.4% during the second quarter. One Wealth Management Investment & Advisory Services LLC now owns 697 shares of the medical equipment provider’s stock worth $310,000 after purchasing an additional 23 shares in the last quarter. 83.64% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling

In other Intuitive Surgical news, EVP Brian Edward Miller sold 2,553 shares of the company’s stock in a transaction that occurred on Tuesday, October 22nd. The stock was sold at an average price of $515.00, for a total value of $1,314,795.00. Following the completion of the transaction, the executive vice president now owns 7,066 shares in the company, valued at $3,638,990. This represents a 26.54 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, SVP Mark Brosius sold 2,128 shares of Intuitive Surgical stock in a transaction that occurred on Tuesday, October 22nd. The shares were sold at an average price of $515.00, for a total transaction of $1,095,920.00. Following the sale, the senior vice president now owns 273 shares in the company, valued at $140,595. This represents a 88.63 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders sold 48,190 shares of company stock valued at $25,012,927. Company insiders own 0.90% of the company’s stock.

Analyst Ratings Changes

A number of research analysts have recently weighed in on the company. Robert W. Baird raised their price target on Intuitive Surgical from $503.00 to $565.00 and gave the company an “outperform” rating in a research report on Thursday, October 17th. Royal Bank of Canada raised their target price on shares of Intuitive Surgical from $525.00 to $555.00 and gave the company an “outperform” rating in a report on Friday, October 18th. Oppenheimer reaffirmed a “market perform” rating on shares of Intuitive Surgical in a report on Friday, October 18th. The Goldman Sachs Group set a $604.00 price objective on shares of Intuitive Surgical in a research note on Friday, October 18th. Finally, Stifel Nicolaus upped their target price on Intuitive Surgical from $525.00 to $610.00 and gave the company a “buy” rating in a research note on Thursday, December 5th. One analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have given a buy rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $550.28.

Intuitive Surgical Price Performance

Intuitive Surgical stock opened at $539.58 on Monday. Intuitive Surgical, Inc. has a 12 month low of $320.26 and a 12 month high of $556.23. The company has a market cap of $192.19 billion, a price-to-earnings ratio of 86.75, a price-to-earnings-growth ratio of 5.35 and a beta of 1.38. The stock’s 50-day moving average is $521.82 and its 200-day moving average is $479.57.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings data on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.24 by $0.32. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. The company had revenue of $2.04 billion during the quarter, compared to the consensus estimate of $2.01 billion. Research analysts anticipate that Intuitive Surgical, Inc. will post 5.45 EPS for the current year.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.